Hyaluronic acid-based hydrogel coatings on Ti6Al4V implantable biomaterial with multifunctional antibacterial activity.

Drug delivery Hyaluronic acid Hydrogel coatings In vivo biocompatibility Multifunctional antibacterial activity Ti6Al4V implants

Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
01 Feb 2023
Historique:
received: 10 09 2022
revised: 14 11 2022
accepted: 15 11 2022
entrez: 29 11 2022
pubmed: 30 11 2022
medline: 2 12 2022
Statut: ppublish

Résumé

Today, the treatment of implant-associated infections with conventional mono-functional antibacterial coatings has not been effective enough for a prosperous long-term implantation. Therefore, biomedical industry is making considerable efforts on the development of novel antibacterial coatings with a combination of more than one antibacterial strategies that interact synergistically to reinforce each other. Therefore, in this work hyaluronic acid-based (HA) hydrogel coatings were created on the surface Ti6Al4V biomaterial with 1,4-butanediol diglycidyl ether (Ti-HABDDE) and divinyl sulfone (Ti-HADVS) crosslinking agents. Hydrogel coatings displayed an extraordinary in vivo biocompatibility, a remarkable ability to promote cell proliferation, differentiation and mineralization, and capability to sustainedly release drugs. Finally, HA-based hydrogel coatings demonstrated an outstanding multifunctional antibacterial activity: bacteria-repelling (51-55 % of S. aureus and 27-40 % of E. coli), bacteria-killing (82-119 % of S. aureus and 83-87 % of E. coli) and bactericide release killing (drug-loaded hydrogel coatings, R > 2).

Identifiants

pubmed: 36446504
pii: S0144-8617(22)01271-1
doi: 10.1016/j.carbpol.2022.120366
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Biocompatible Materials 0
Hyaluronic Acid 9004-61-9
Hydrogels 0
titanium alloy (TiAl6V4) 12743-70-3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120366

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jon Andrade Del Olmo (J)

i+Med S. Coop. Parque Tecnológico de Álava, Albert Einstein 15, nave 15, 01510 Vitoria-Gasteiz, Spain; Grupo de Química Macromolecular (LABQUIMAC), Departamento de Química Física, Facultad de Ciencia y Tecnología, Universidad del País Vasco UPV/EHU, 48940 Leioa, Spain.

José María Alonso (JM)

i+Med S. Coop. Parque Tecnológico de Álava, Albert Einstein 15, nave 15, 01510 Vitoria-Gasteiz, Spain. Electronic address: jalonso@imasmed.com.

Virginia Sáez-Martínez (V)

i+Med S. Coop. Parque Tecnológico de Álava, Albert Einstein 15, nave 15, 01510 Vitoria-Gasteiz, Spain.

Sandra Benito-Cid (S)

i+Med S. Coop. Parque Tecnológico de Álava, Albert Einstein 15, nave 15, 01510 Vitoria-Gasteiz, Spain.

Raúl Pérez-González (R)

i+Med S. Coop. Parque Tecnológico de Álava, Albert Einstein 15, nave 15, 01510 Vitoria-Gasteiz, Spain.

José Luis Vilas-Vilela (JL)

Grupo de Química Macromolecular (LABQUIMAC), Departamento de Química Física, Facultad de Ciencia y Tecnología, Universidad del País Vasco UPV/EHU, 48940 Leioa, Spain; BCMaterials, Basque Center for Materials, Applications and Nanostructures, UPV/EHU Science Park, 48940 Leioa, Spain.

Leyre Pérez-Álvarez (L)

Grupo de Química Macromolecular (LABQUIMAC), Departamento de Química Física, Facultad de Ciencia y Tecnología, Universidad del País Vasco UPV/EHU, 48940 Leioa, Spain; BCMaterials, Basque Center for Materials, Applications and Nanostructures, UPV/EHU Science Park, 48940 Leioa, Spain.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Humans Hyaluronic Acid Osteoarthritis, Hip Female Middle Aged
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH